VivoSim Labs (VIVS) Total Non-Current Liabilities (2011 - 2014)
VivoSim Labs (VIVS) posted Total Non-Current Liabilities of $1.5 million for Q1 2014, down 20.07% on a QoQ basis from $1.9 million in Q4 2013, and up 1.13% year-over-year from $1.5 million in Q1 2013.
Analysis
VivoSim Labs (VIVS) Total Non-Current Liabilities (2011 - 2014) Analysis & Trends
VivoSim Labs has reported Total Non-Current Liabilities for 4 years, with the latest figure at $1.5 million in Q1 2014.
- On a quarterly basis, Total Non-Current Liabilities rose 1.13% year-over-year to $1.5 million in Q1 2014; TTM through Mar 2014 was $1.5 million, a 1.13% increase from a year earlier, with the FY2014 full-year figure at $1.5 million, up 1.13% from the prior year.
- Total Non-Current Liabilities was $1.5 million for Q1 2014 at VivoSim Labs, down from $1.9 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $2.2 million in Q3 2013, with the low at -$1.0 million in Q3 2012.
- Average Total Non-Current Liabilities over 4 years is $1.3 million, with a median of $1.5 million recorded in 2013.
- The sharpest annual moves came in 2012 and 2013: Total Non-Current Liabilities decreased 27.52% in 2012, then jumped 315.23% in 2013.
- Over 4 years, Total Non-Current Liabilities stood at $2.0 million in 2011, then decreased by 27.52% to $1.4 million in 2012, then soared by 33.15% to $1.9 million in 2013, then dropped by 20.07% to $1.5 million in 2014.
- The last three Total Non-Current Liabilities figures came in at $1.5 million (Q1 2014), $1.9 million (Q4 2013), and $2.2 million (Q3 2013), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 22.94 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.56 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 6.94 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 4.24 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.15 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 30.49 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 553.39 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 28.62 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2014 | 1.53 Mn |
| Dec 31, 2013 | 1.91 Mn |
| Sep 30, 2013 | 2.16 Mn |
| Mar 31, 2013 | 1.51 Mn |
| Dec 31, 2012 | 1.43 Mn |
| Sep 30, 2012 | -1.00 Mn |
| Jun 30, 2012 | 889,006.00 |
| Mar 31, 2012 | 1.11 Mn |
| Dec 31, 2011 | 1.98 Mn |